Skip to content

Advertisement

Open Peer Review Reports for: Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
30 May 2017 Submitted Original manuscript
16 Jul 2017 Reviewed Reviewer Report - Parakkal Deepak
17 Jul 2017 Reviewed Reviewer Report - Afsaneh Oskouie
26 Jul 2017 Reviewed Reviewer Report - Peter Adriaensens
25 Aug 2017 Author responded Author comments - jacob bjerrum
Resubmission - Version 2
25 Aug 2017 Submitted Manuscript version 2
10 Sep 2017 Reviewed Reviewer Report - Peter Adriaensens
16 Sep 2017 Reviewed Reviewer Report - Afsaneh Oskouie
21 Sep 2017 Reviewed Reviewer Report - Parakkal Deepak
27 Sep 2017 Author responded Author comments - jacob bjerrum
Resubmission - Version 3
27 Sep 2017 Submitted Manuscript version 3
Publishing
29 Sep 2017 Editorially accepted
16 Oct 2017 Article published 10.1186/s12916-017-0949-7

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement